Cryopreservative compostions and methods
Abstract
This disclosure describes compositions and methods related to cryoprotection of biomaterial. Generally, the cryoprotective composition includes a cryoprotective agent and magnetic nanoparticles effective for thawing a cryopreserved specimen comprising biomaterial with minimal biomaterial damage. In some embodiments, the composition is effective for thawing a cryopreserved specimen having a minimum dimension of 0.1 mm. Generally, the method includes obtaining a biomaterial cryopreserved with a cryoprotective composition as summarized above, then subjecting the cryopreserved biomaterial to electromagnetic energy of an intensity sufficient to excite the magnetic nanoparticles and thaw the biomaterial.
Claims
exact text as granted — not AI-modified1 . A cryoprotective composition comprising:
a cryoprotective agent and magnetic nanoparticles effective for thawing a cryopreserved specimen comprising biomaterial with minimal biomaterial damage.
2 . The composition of claim 1 wherein the cryopreserved specimen has a minimum dimension of 0.1 mm.
3 . The composition of claim 1 wherein the cryoprotective agent has a molarity of no more than 9 M.
4 . The composition of claim 1 wherein the magnetic nanoparticles comprise superparamagnetic nanoparticles.
5 . The composition of claim 1 wherein the magnetic nanoparticles comprise ferromagnetic nanoparticles.
6 . The method of claim 1 wherein the total concentration of magnetic nanoparticles comprises 0.01 mg Fe/mL to 100 mg Fe/mL.
7 . The composition of claim 1 wherein the damage comprises cracking
8 . The composition of claim 1 wherein the damage comprises devitrification.
9 . The composition of claim 1 wherein minimal damage comprises sufficiently minimal structural damage to the biomaterial that the biomaterial is suitable for transplantation.
10 . A composition comprising:
a biomaterial perfused with a cryoprotective composition comprising:
a cryoprotective agent; and
magnetic nanoparticles effective for thawing a cryopreserved specimen comprising biomaterial with minimal biomaterial damage.
11 . The composition of claim 10 wherein the biomaterial comprises an organ or portion thereof, a tissue or portion thereof, or cells.
12 . A composition comprising:
a biomaterial suspended in a cryoprotective composition comprising:
a cryoprotective agent; and
magnetic nanoparticles effective for thawing a cryopreserved specimen comprising biomaterial with minimal biomaterial damage.
13 . The composition of claim 12 wherein the biomaterial comprises an organ or portion thereof, a tissue or portion thereof, or cells.
14 . A method of thawing a cryopreserved biomaterial, the method comprising:
obtaining a biomaterial cryopreserved with a cryoprotective composition comprising:
a cryoprotective agent; and
magnetic nanoparticles effective for thawing a cryopreserved specimen comprising biomaterial with minimal biomaterial damage; and
subjecting the cryopreserved biomaterial to electromagnetic energy of an intensity sufficient to excite the magnetic nanoparticles and thaw the biomaterial.
15 . The method of claim 14 wherein the electromagnetic energy comprises a radio frequency field, an alternating magnetic field, or a rotating magnetic field.
16 . The method of claim 15 wherein the radio frequency field, alternating magnetic field, or rotating magnetic field comprises a frequency of 0 kHz to 10 MHz.
17 . The method of claim 14 wherein the cryopreserved biomaterial is perfused with the cryoprotective composition.
18 . The method of claim 14 wherein the cryopreserved biomaterial is suspended in the cryoprotective composition.
19 . The method of claim 14 wherein the cryopreserved biomaterial has a volume with a minimum dimension of at least 0.1 mm.
20 . The method of claim 14 wherein the cryopreserved biomaterial is thawed with minimal damage.
21 . The method of claim 20 wherein the damage comprises devitrification.
22 . The method of claim 20 wherein the damage comprises cracking
23 . The method of claim 14 wherein the cryopreserved biomaterial is warmed at a rate of at least 10° C./minute throughout.
24 . The method of claim 14 wherein subjecting the cryopreserved biomaterial to electromagnetic energy of an intensity sufficient to thaw the cryopreserved biomaterial generates a thermal gradient of no more than 1° C./mm within the biomaterial.Join the waitlist — get patent alerts
Track US2016015025A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.